Y. Kulyaba

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Y. Kulyaba is an author at Istanbul University-Cerrahpaşa specializing in chemotherapy, tumor progression, and non-small cell lung cancer immunotherapy.

Publications per year

2022–2022

Publications

LBA54 Three years survival outcome and continued cemiplimab (CEMI) beyond progression with the addition of chemotherapy (chemo) for patients (pts) with advanced non-small cell lung cancer (NSCLC): The EMPOWER-Lung 1 trial

Mustafa Özgüroğlu, A. Sezer, Igor Bondarenko et al. · Annals of Oncology · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacology +11

1–1 of 1